Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06636682 |
| Title | FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Cellvax Therapeutics Inc |
| Indications | |
| Therapies | |
| Age Groups: | child | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic | ACTIVE_NOT_RECRUITING | Chicago | Illinois | 60637 | United States | Details |
| Central Ohio Urology Group | RECRUITING | Gahanna | Ohio | 43230 | United States | Details |
| Carolina Urologic Research Center | RECRUITING | Myrtle Beach | South Carolina | 29572 | United States | Details |